3-(3,4-Dimethoxyphenyl)-8H-thieno[2,3-b]pyrrolizin-8-one | 258269-95-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(3,4-Dimethoxyphenyl)-8H-thieno[2,3-b]pyrrolizin-8-one
• 英文别名: 3-(3,4-dimethoxyphenyl)thieno[2,3-b]pyrrolizin-8-one
• CAS: 258269-95-3
• 化学式: C₁₇H₁₃NO₃S
• 分子量: 311.361
• InChiKey: JVGRPRWJAOKUME-UHFFFAOYSA-N

物化性质

• 熔点：
  190 °C
• 沸点：
  462.6±45.0 °C(Predicted)
• 密度：
  1.37±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  22
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  68.7
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-(3,4-Dimethoxyphenyl)-8H-thieno[2,3-b]pyrrolizin-8-one 在 aluminium chloride 作用下， 以 氯仿 、 水 为溶剂， 生成 3-(3-hydroxy-4-methoxy)phenyl-8H-thieno[2,3-b]pyrrolizin-8-one
  参考文献：
  名称：

  8H-thieno-[2,3-b]pyrrolizin-8-one compounds

  摘要：

  从公式（I）中选择的化合物：##STR1## 其中： R.sub.1代表氢，卤素，烷基，硝基，羟基，烷氧基，三卤代烷基，三卤代烷氧基或可选择取代的氨基，R.sub.2代表可选择取代的芳基或杂环基，R.sub.3代表氢，卤素，烷基，硝基，羟基，烷氧基，三卤代烷基，三卤代烷氧基或可选择取代的氨基，它们的异构体和相应的药学上可接受的酸或碱盐以及含有它们的药物制剂在癌症治疗中有用。

  公开号：

  US06071945A1
• 作为产物：
  描述：

  3,4-二甲氧基苯乙腈 在 sodium methylate 、 4-氯吡啶盐酸盐 、 三氯氧磷 作用下， 以 1,4-二氧六环 、 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 14.75h， 生成 3-(3,4-Dimethoxyphenyl)-8H-thieno[2,3-b]pyrrolizin-8-one
  参考文献：
  名称：

  Design, Synthesis, and Evaluation of Novel Thienopyrrolizinones as Antitubulin Agents

  摘要：

  Herein, we describe the structure-activity relationship study of a new 3-aryl-8H-thieno[2,3-b]pyrrolizin-8-one series of antitubulin agents. The pharmacological results from the National Cancer Institute in vitro human disease oriented tumor cell line screening allowed us to identify compound 1d (NSC 676693) as a very efficient antitumoral drug in all cancer cell lines tested. This prompted us to define the structural requirements essential for this antiproliferative activity. Among all analogues synthesized in this study, compound 1o was the most promising, being 10-fold more potent than compound 1d. Its activity over a panel of nine tumoral cell lines was in the nanomolar range for all of the histological types tested, and surprisingly, the resistant KB-A1 cell line was also sensitive to this compound. Moreover, a flow cytometric study showed that L1210 cells treated by the most potent compounds were arrested in the G(2)/M phases of the cell cycle with a significant percentage of cells having reinitiated a cycle of DNA synthesis without cell division. This interesting pharmacological profile, resulting from inhibition of tubulin polymerization, encouraged us to perform preliminary in vivo studies that led to a new prodrug chemical approach.

  DOI：

  10.1021/jm030961z

文献信息

• Dérivés de 8H-(2,3-b)-pyrrolizine-8-one, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
  申请人：ADIR ET COMPAGNIE

  公开号：EP0982308A1

  公开（公告）日：2000-03-01

  Composés de formule (I) dans laquelle : R1représente un atome d'hydrogène. d'halogène, un groupement alkyle, nitro, hydroxy, alkoxy, trihalogénoalkyle, trihalogénoalkoxy ou amino éventuellement substitué, R2représente un groupement aryle ou hétéroaryle éventuellement substitués, R3représente un atome d'hydrogène, d'halogène, un groupement alkyle, nitro, hydroxy, alkoxy, trihalugénoalkyle, trihalogénoalkoxy ou amino éventuellement substitué, leurs isomères ainsi que leurs sels d'addition à un acide ou à une base pharmaceutiquement acceptable. Médicaments.

  式(I)化合物 其中： R1 代表氢原子或卤素原子或任选取代的烷基、硝基、羟基、烷氧基、三卤烷基、三卤烷氧基或氨基、 R2 代表任选取代的芳基或杂芳基、 R3 代表氢原子、卤素原子或任选取代的烷基、硝基、羟基、烷氧基、三卤烷基、三卤烷氧基或氨基、 它们的异构体及其与药学上可接受的酸或碱的加成盐。 药用产品。
• Design, synthesis and antiproliferative activity of tripentones: A new series of antitubulin agents
  作者：Vincent Lisowski、Cécile Enguehard、Jean-Charles Lancelot、Daniel-Henri Caignard、Stéphanie Lambel、Stéphane Leonce、Alain Pierre、Ghanem Atassi、Pierre Renard、Sylvain Rault

  DOI：10.1016/s0960-894x(01)00403-6

  日期：2001.8

  Structure-activity relationship studies of a new series of tripentones (thieno[2.3-h]pyrrolizin-8-ones), led us to prepare several derivatives with antiproliferative activities. The most promising 3-(3-hydroxy-4-methoxyphenyl)thieno[2.3-b]pyrrolizin-8-one 20 (leukemia L1210. IC50= 15 nM) was shown to be a potent inhibitor of tubulin polymerization. (C) 2001 Elsevier Science Ltd. All rights reserved.
• US6071945A
  申请人：——

  公开号：US6071945A

  公开（公告）日：2000-06-06
• Design, Synthesis, and Evaluation of Novel Thienopyrrolizinones as Antitubulin Agents
  作者：Vincent Lisowski、Stéphane Léonce、Laurence Kraus-Berthier、Jana Sopková-de Oliveira Santos、Alain Pierré、Ghanem Atassi、Daniel-Henri Caignard、Pierre Renard、Sylvain Rault

  DOI：10.1021/jm030961z

  日期：2004.3.1

  Herein, we describe the structure-activity relationship study of a new 3-aryl-8H-thieno[2,3-b]pyrrolizin-8-one series of antitubulin agents. The pharmacological results from the National Cancer Institute in vitro human disease oriented tumor cell line screening allowed us to identify compound 1d (NSC 676693) as a very efficient antitumoral drug in all cancer cell lines tested. This prompted us to define the structural requirements essential for this antiproliferative activity. Among all analogues synthesized in this study, compound 1o was the most promising, being 10-fold more potent than compound 1d. Its activity over a panel of nine tumoral cell lines was in the nanomolar range for all of the histological types tested, and surprisingly, the resistant KB-A1 cell line was also sensitive to this compound. Moreover, a flow cytometric study showed that L1210 cells treated by the most potent compounds were arrested in the G(2)/M phases of the cell cycle with a significant percentage of cells having reinitiated a cycle of DNA synthesis without cell division. This interesting pharmacological profile, resulting from inhibition of tubulin polymerization, encouraged us to perform preliminary in vivo studies that led to a new prodrug chemical approach.
• 8H-thieno-[2,3-b]pyrrolizin-8-one compounds
  申请人：Adir et Compagnie

  公开号：US06071945A1

  公开（公告）日：2000-06-06

  A compound selected from those of formula (I): ##STR1## wherein: R.sub.1 represents hydrogen, halogen, alkyl, nitro, hydroxy, alkoxy, trihaloalkyl, trihaloalkoxy or optionally substituted amino, R.sub.2 represents optionally substituted aryl or heteroaryl, R.sub.3 represents hydrogen, halogen, alkyl, nitro, hydroxy, alkoxy, trihaloalkyl, trihaloalkoxy or optionally substituted amino, their isomers and addition pharmaceutically-acceptable acid or base salts thereof and medicinal products containing the same are useful in the treatment of cancer.

  从公式（I）中选择的化合物：##STR1## 其中： R.sub.1代表氢，卤素，烷基，硝基，羟基，烷氧基，三卤代烷基，三卤代烷氧基或可选择取代的氨基，R.sub.2代表可选择取代的芳基或杂环基，R.sub.3代表氢，卤素，烷基，硝基，羟基，烷氧基，三卤代烷基，三卤代烷氧基或可选择取代的氨基，它们的异构体和相应的药学上可接受的酸或碱盐以及含有它们的药物制剂在癌症治疗中有用。